Related Experiment Video
Updated: May 23, 2026

Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using BrdU-ChIP-Slot-Western Technique
Published on: January 14, 2016
Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic
André Brandl1, Tobias Wagner, Katharina M Uhlig
1Center for Molecular Biomedicine, Institute for Biochemistry and Biophysics, Department of Biochemistry, Friedrich Schiller University of Jena, Hans-Knöll-Straße 2, 07745 Jena, Germany.
Abstract:
Histone deacetylase 2 (HDAC2) is relevant for homeostasis and plays a critical role in gastrointestinal cancers. Here, we report that post-translational modification of endogenous HDAC2 with small ubiquitin-related modifier 1 (SUMO1) is a new regulatory switch for the tumor suppressor p53. Sumoylation of HDAC2 at lysine 462 allows binding of HDAC2 to p53. Moreover, sumoylated HDAC2 is a previously not recognized biologically relevant site-specific deacetylase for p53. Deacetylation of p53 at lysine 320 by sumoylated HDAC2 blocks recruitment of p53 into promoter-associated complexes and p53-dependent expression of genes for cell cycle control and apoptosis. Thereby, catalytically active sumoylated HDAC2 restricts p53 functions and attenuates DNA damage-induced apoptosis. Genotoxic stress evokes desumoylation of HDAC2, enabling p53-dependent gene expression. Our data show a new molecular mechanism involving a dynamically controlled HDAC2-sumoylation/p53-acetylation switch that regulates cell fate decisions following genotoxic stress.
Insights
Small ubiquitin-related modifier 1 (SUMO1) modification of histone deacetylase 2 (HDAC2) regulates the tumor suppressor p53. This SUMO1-HDAC2 interaction impacts cell fate decisions following genotoxic stress.
Area of Science:
- Molecular Biology
- Cancer Biology
- Biochemistry
Background:
- Histone deacetylase 2 (HDAC2) is crucial for homeostasis and gastrointestinal cancer.
- Post-translational modifications regulate protein function and cellular processes.
Purpose of the Study:
- To investigate the role of HDAC2 sumoylation in regulating the tumor suppressor p53.
- To elucidate the molecular mechanism by which sumoylated HDAC2 affects p53 activity and downstream gene expression.
Main Methods:
- Western blotting and immunoprecipitation to detect and analyze protein modifications.
- Chromatin immunoprecipitation assays to assess protein-DNA interactions.
- Reporter gene assays to measure gene expression levels.
Main Results:
- Endogenous HDAC2 is modified by small ubiquitin-related modifier 1 (SUMO1) at lysine 462.
- Sumoylated HDAC2 binds to and deacetylates p53 at lysine 320.
- Deacetylation of p53 by sumoylated HDAC2 inhibits p53-dependent gene expression and apoptosis.
- Genotoxic stress induces desumoylation of HDAC2, restoring p53 function.
Conclusions:
- A novel regulatory switch involving HDAC2 sumoylation/p53 acetylation controls cell fate decisions after genotoxic stress.
- Sumoylated HDAC2 acts as a site-specific deacetylase for p53, restricting its tumor suppressor functions.
- Targeting the HDAC2-sumoylation pathway may offer new therapeutic strategies for gastrointestinal cancers.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

